Buprenorphine MAT as an Imperfect Fix

Journal of Law, Medicine and Ethics 46 (2):279-291 (2018)
  Copy   BIBTEX

Abstract

Expanding buprenorphine access in the United States requires evidence-based decision-making that considers both the drug's potential dangers and its potential benefits. Risks associated with buprenorphine misuse and diversion highlight the need for careful, ongoing evaluation during each stage of increased access.

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 104,143

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Addiction: lifestyle choice or medical diagnosis?David Nutt - 2013 - Journal of Evaluation in Clinical Practice 19 (3):493-496.
Biopreserving Pathogens: Promise & Peril.Justyna Jaskiewicz, Susan M. Wolf, Mehmet Toner & Rebecca D. Sandlin - 2024 - Journal of Law, Medicine and Ethics 52 (3):624-636.
Equitable Access to Nature and Transformational Politics.Victor Thasiah - 2024 - Buddhist-Christian Studies 44 (1):169-173.

Analytics

Added to PP
2018-07-20

Downloads
36 (#687,985)

6 months
14 (#221,552)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Letter to the Editor.Corey S. Davis & Derek H. Carr - 2018 - Journal of Law, Medicine and Ethics 46 (3):811-812.

Add more citations

References found in this work

Physician Autonomy and the Opioid Crisis.Nathan Guevremont, Mark Barnes & Claudia E. Haupt - 2018 - Journal of Law, Medicine and Ethics 46 (2):203-219.

Add more references